Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$73.27 - $83.09 $8,719 - $9,887
-119 Reduced 2.21%
5,270 $426,000
Q3 2023

Nov 07, 2023

SELL
$73.94 - $80.67 $99,892 - $108,985
-1,351 Reduced 20.04%
5,389 $403,000
Q2 2023

Aug 10, 2023

SELL
$76.01 - $86.7 $6,080 - $6,936
-80 Reduced 1.17%
6,740 $519,000
Q1 2023

May 10, 2023

BUY
$77.31 - $88.08 $22,265 - $25,367
288 Added 4.41%
6,820 $565,000
Q4 2022

Feb 09, 2023

BUY
$62.32 - $89.47 $407,074 - $584,418
6,532 New
6,532 $560,000
Q2 2022

Aug 09, 2022

SELL
$57.72 - $65.01 $93,737 - $105,576
-1,624 Reduced 3.18%
49,444 $3.06 Million
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $2.96 Million - $3.71 Million
51,068 New
51,068 $3.04 Million
Q1 2020

May 08, 2020

SELL
$62.63 - $80.22 $209,935 - $268,897
-3,352 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$61.62 - $67.78 $5.19 Million - $5.7 Million
-84,146 Reduced 96.17%
3,352 $218,000
Q3 2018

Nov 15, 2018

BUY
$71.28 - $78.92 $5.24 Million - $5.81 Million
73,559 Added 527.72%
87,498 $6.76 Million
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $1.08 Million - $1.26 Million
-16,681 Reduced 54.48%
13,939 $987,000
Q1 2018

May 07, 2018

SELL
$72.84 - $88.8 $3.11 Million - $3.79 Million
-42,699 Reduced 58.24%
30,620 $2.31 Million
Q4 2017

Feb 08, 2018

BUY
$71.15 - $83.52 $143,367 - $168,292
2,015 Added 2.83%
73,319 $5.25 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $5.14 Million - $6.09 Million
71,304
71,304 $5.78 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.